NeuraLight, the leader in developing precision neuroprogression biomarkers for neurological disease, today announced the completion of PALOMA, a pioneering study comparing eye-movement measures with ...
SAN FRANCISCO — Two different balloon devices developed for the treatment of calcified coronary lesions were found noninferior to intravascular lithotripsy (IVL) at a lower cost in separate major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback